1.Bailey, LB, Stover, PJ, McNulty, H et al. (2015) Biomarkers of nutrition for development – folate review. J Nutr 147, 1636S–1680S.
2.MRC Vitamin Study Research Group (1991) Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 338, 131–137.
3.Czeizel, AE & Dudas, I (1992) Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 327, 1832–1835.
4.Department of Health (1992) .
5.CDC (1992) Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR Recomm Rep 41, 1–7.
6.Wills, L (1931) Treatment of ‘pernicious anaemia of pregnancy’ and ‘tropical anaemia’ with special reference to yeast extract as a curative agent. Br Med J 1, 1059–1064.
7.Chanarin, I (1985) Folate and cobalamin. Clin Haematol 14, 629–641.
8.Hall, MH, Pirani, BBK & Campbell, D (1976) The cause of the fall in serum folate in normal pregnancy. Br J Obs Gynaecol 83, 132–136.
9.McNulty, B, McNulty, H, Marshall, B et al. (2013) Impact of continuing folic acid after the first trimester of pregnancy: findings of a randomized trial of folic acid supplementation in the second and third trimesters. Am J Clin Nutr 98, 92–98.
10.Fletcher, J, Gurr, A, Fellingham, F et al. (1971) The value of folic acid supplements in pregnancy. J Obs Gynaecol Br Commonw 78, 781–785.
11.Blot, I, Papiernik, E, Kaltwasser, JP et al. (1981) Influence of routine administration of folic acid and iron during pregnancy. Gynecol Obstet Invest 12, 294–304.
12.Homocysteine Lowering Trialists’ Collaboration (2005) Dose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials. Am J Clin Nutr 82, 806–812.
13.Mills, JL, Lee, YJ, Conley, MR et al. (1995) Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet 345, 149–151.
14.Felkner, M, Suarez, L, Canfield, MA et al. (2009) Maternal serum homocysteine and risk for neural tube defects in a Texas-Mexico border population. Birth Defects Res Part A – Clin Mol Teratol 85, 574–581.
15.Cotter, AM, Molloy, AM, Scott, JM et al. (2001) Elevated plasma homocysteine in early pregnancy: a risk factor for the development of severe preeclampsia. Am J Obstet Gynecol 185, 781–785.
16.Cotter, AM, Molloy, AM, Scott, JM et al. (2003) Elevated plasma homocysteine in early pregnancy: a risk factor for the development of nonsevere preeclampsia. Am J Obstet Gynecol 189, 391–394.
17.Goddijn-Wessel, TA, Wouters, MG, van de Molen, EF et al. (1996) Hyperhomocysteinemia: a risk factor for placental abruption or infarction. Eur J Obstet Gynecol Reprod Biol 66, 23–29.
18.Nelen, WLDM, Blom, HJ, Steegers, EAP et al. (2000) Hyperhomocysteinemia and recurrent early pregnancy loss: a meta-analysis. Fertil Steril 74, 1196–1199.
19.Vollset, SE, Refsum, H, Irgens, LM et al. (2000) Plasma total homocysteine, pregnancy complications, and adverse pregnancy outcomes: the Hordaland Homocysteine Study. Am J Clin Nutr 71, 962–968.
20.Caffrey, A, McNulty, H, Irwin, RE et al. (2019) Maternal folate nutrition and offspring health: evidence and current controversies. Proc Nutr Soc 78, 208–220.
21.Julvez, J, Fortuny, J, Mendez, M et al. (2009) Maternal use of folic acid supplements during pregnancy and four-year-old neurodevelopment in a population-based birth cohort. Paediatr Perinat Epidemiol 23, 199–206.
22.Veena, SR, Krishnaveni, GV, Srinivasan, K et al. (2010) Higher maternal plasma folate but not vitamin B-12 concentrations during pregnancy are associated with better cognitive function scores in 9- to 10- year-old children in South India. J Nutr 140, 1014–1022.
23.Polańska, K, Muszyński, P, Sobala, W et al. (2015) Maternal lifestyle during pregnancy and child psychomotor development – Polish Mother and Child Cohort study. Early Hum Dev 91, 317–325.
24.Pentieva, K, McGarel, C, McNulty, BA et al. (2012) Effect of folic acid supplementation during pregnancy on growth and cognitive development of the offspring: a pilot follow-up investigation of children of FASSTT study participants. Proc Nutr Soc 71(OCE2), E139 .
25.McGarel, C, Pentieva, K, Strain, JJ et al. (2015) Emerging roles for folate and related B-vitamins in brain health across the lifecycle. Proc Nutr Soc 74, 46–55.
26.James, P, Sajjadi, S, Tomar, AS et al. (2018) Candidate genes linking maternal nutrient exposure to offspring health via DNA methylation: a review of existing evidence in humans with specific focus on one-carbon metabolism. Int J Epidemiol 47, 1910–1937.
27.Caffrey, A, Irwin, RE, McNulty, H et al. (2018) Gene-specific DNA methylation in newborns in response to folic acid supplementation during the second and third trimesters of pregnancy: epigenetic analysis from a randomized controlled trial. Am J Clin Nutr 107, 566–575.
28.Ly, A, Ishiguro, L, Kim, D et al. (2016) Maternal folic acid supplementation modulates DNA methylation and gene expression in the rat offspring in a gestation period-dependent and organ-specific manner. J Nutr Biochem 33, 103–110.
29.Kerr, MA, Livingstone, B, Bates, CJ et al. (2009) Folate, related B vitamins, and homocysteine in childhood and adolescence: potential implications for disease risk in later life. Pediatrics 123, 627–635.
30.Pfeiffer, CM, Hughes, JP, Lacher, DA et al. (2012) Estimation of trends in serum and RBC folate in the U.S. population from pre- to postfortification using assay-adjusted data from the NHANES 1988–2010. J Nutr 142, 886–893.
31.McNulty, H, Strain, JJ, Hughes, CF et al. (2017) Riboflavin, MTHFR genotype and blood pressure: a personalized approach to prevention and treatment of hypertension. Mol Aspects Med 53, 2–9.
32.Lim, SS, Vos, T, Flaxman, AD et al. (2012) A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380, 2224–2260.
34.Mozaffarian, D, Benjamin, EJ, Go, AS et al. (2016) Heart disease and stroke statistics – 2016 update a report from the American Heart Association. Circulation 133, e38–e48.
35.Lewington, S, Clarke, R, Qizilbash, N et al. (2002) Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360, 1903–1913.
36.Newton-Cheh, C, Johnson, T, Gateva, V et al. (2009) Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet 41, 666–676.
37.Ehret, GB, Munroe, PB, Rice, KM et al. (2011) Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature 478, 103–109.
38.Yang, B, Fan, S, Zhi, X et al. (2014) Associations of MTHFR gene polymorphisms with hypertension and hypertension in pregnancy: a meta-analysis from 114 studies with 15411 cases and 21970 controls. PLoS ONE 9, e87497.
39.Holmes, MV, Newcombe, P, Hubacek, JA et al. (2011) Effect modification by population dietary folate on the association between MTHFR genotype, homocysteine, and stroke risk: a meta-analysis of genetic studies and randomised trials. Lancet 378, 584–594.
40.Frosst, P, Blom, HJ, Milos, R et al. (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10, 111–113.
41.Yamada, K, Chen, Z, Rozen, R et al. (2001) Effects of common polymorphisms on the properties of recombinant human methylenetetrahydrofolate reductase. Proc Natl Acad Sci 98, 14853–14858.
42.Pejchal, R, Campbell, E, Guenther, BD et al. (2006) Structural perturbations in the Ala → Val polymorphism of methylenetetrahydrofolate reductase: how binding of folates may protect against inactivation. Biochemistry 45, 4808–4818.
43.Molloy, AM, Daly, S, Mills, JL et al. (1997) Thermolabile variant of 5, 10-methylenetetrahydrofolate reductase associated with low red-cell folates: implications for folate intake recommendations. Lancet 349, 1591–1593.
44.Jacques, PF, Bostom, AG, Williams, RR et al. (1996) Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 93, 7–9.
45.McNulty, H, McKinley, MC, Wilson, B et al. (2002) Impaired functioning of thermolabile methylenetetrahydrofolate reductase is dependent on riboflavin status: implications for riboflavin requirements. Am J Clin Nutr 76, 436–441.
46.Hustad, S, Midttun, Ø, Schneede, J et al. (2007) The methylenetetrahydrofolate reductase 677C→T polymorphism as a modulator of a B-vitamin network with major effects on homocysteine metabolism. Am J Hum Genet 80, 846–855.
47.McNulty, H, Dowey, LRC, Strain, JJ et al. (2006) Riboflavin lowers homocysteine in individuals homozygous for the MTHFR 677C→T polymorphism. Circulation 113, 74–80.
48.Horigan, G, McNulty, H, Ward, M et al. (2010) Riboflavin lowers blood pressure in cardiovascular disease patients homozygous for the 677C→T polymorphism in MTHFR. J Hypertens 28, 478–486.
49.Wilson, CP, Ward, M, McNulty, H et al. (2012) Riboflavin offers a targeted strategy for managing hypertension in patients with the MTHFR 677TT genotype: a 4-y follow-up. Am J Clin Nutr 95, 766–772.
50.Wilson, CP, McNulty, H, Ward, M et al. (2013) Blood pressure in treated hypertensive individuals with the mthfr 677TT genotype is responsive to intervention with riboflavin: findings of a targeted randomized trial. Hypertension 61, 1302–1308.
52.Prince, MJ, Comas-Herrera, A, Knapp, M et al. (2016) World Alzheimer Report 2016 Improving Healthcare for People Living with Dementia Coverage, Quality and Costs Now and in the Future. London: Alzheimer's Disease International.
53.National Collaborating Centre for Mental Health (2010) The Treatment and Management of Depression in Adults (Updated Edition) National Clinical Practice Guideline 90. Leicester: The British Psychological Society and The Royal College of Psychiatrists.
54.O'Shea, E & Kennelly, E (2008) The economics of mental healthcare Ireland. Galway: NUI, Mental Health Commission.
55.Calder, PC, Carding, SR, Christopher, G et al. (2018) A holistic approach to healthy ageing: how can people live longer, healthier lives? J Hum Nutr Diet 31, 439–450.
56.Gauthier, S, Reisberg, B, Zaudig, M et al. (2006) Mild cognitive impairment. Lancet 367, 1262–1270.
57.Craig, R & Mindell, J (2007) Health Survey for England 2005: The Health of Older People. London: The Information Centre.
58.Panza, F, Frisardi, V, Capurso, C et al. (2010) Late-life depression, mild cognitive impairment, and dementia: possible continuum? Am J Geriatr Psychiatry 18, 98–116.
59.Brailean, A, Aartsen, MJ, Muniz-Terrera, G et al. (2017) Longitudinal associations between late-life depression dimensions and cognitive functioning: a cross-domain latent growth curve analysis. Psychol Med 47, 690–702.
60.Moore, K, Hughes, CF, Ward, M et al. (2018) Diet, nutrition and the ageing brain: current evidence and new directions. Proc Nutr Soc 77, 152–163.
61.Carney, MWP (1967) Serum folate values in 423 psychiatric patients. Br Med J 4, 512–516.
62.Reynolds, EH, Preece, JM, Bailey, J et al. (1970) Folate deficiency in depressive illness. Br J Psychiatry 117, 287–292.
63.Strachan, RW & Henderson, JG (1965) Psychiatric syndromes due to avitaminosis B 12 with normal blood and marrow. Q J Med 34, 303–317.
64.Shorvon, SD, Carney, MWP, Chanarin, I et al. (1980) The neuropsychiatry of megaloblastic anaemia. Br Med J 281, 1036–1038.
65.Reynolds, E (2006) Vitamin B12, folic acid, and the nervous system. Lancet Neurol 5, 949–960.
66.Selhub, J, Bagley, LC, Miller, J et al. (2000) B vitamins, homocysteine, and neurocognitive function in the elderly. Am J Clin Nutr 71, 614S–620S.
67.Bottiglieri, T, Laundy, M, Crellin, R et al. (2000) Homocysteine, folate, methylation, and monoamine metabolism in depression. J Neurol Neurosurg Psychiatry 69, 228–232.
68.Smith, AD & Refsum, H (2016) Homocysteine, B-vitamins, and cognitive impairment. Annu Rev Nutr 36, 211–239.
69.Carney, MW, Ravindran, A, Rinsler, MG et al. (1982) Thiamine, riboflavin and pyridoxine deficiency in psychiatric in-patients. Br J Psychiatry 141, 271–272.
70.Porter, K, Hoey, L, Hughes, CF et al. (2016) Causes, consequences and public health implications of low B-vitamin status in ageing. Nutrients 8, 1–29.
71.McMahon, JA, Green, TJ, Skeaff, CM et al. (2006) A controlled trial of homocysteine lowering and cognitive performance. N Engl J Med 354, 2764–2772.
72.Durga, J, van Boxtel, MP, Schouten, EG et al. (2007) Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial. Lancet 369, 208–216.
73.De Jager, CA, Oulhaj, A, Jacoby, R et al. (2012) Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial. Int J Geriatr Psychiatry 27, 592–600.
74.Smith, AD, Smith, SM, de Jager, CA et al. (2010) Homocysteine-lowering by B-vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial. PLoS ONE 5, e12244.
75.Douaud, G, Refsum, H, de Jager, CA et al. (2013) Preventing Alzheimer's disease-related gray matter atrophy by B-vitamin treatment. Proc Natl Acad Sci 110, 9523–9528.
76.Clarke, R, Bennett, D, Parish, S et al. (2014) Effects of homocysteine lowering with B vitamins on cognitive aging: meta-analysis of 11 trials with cognitive data on 22,000 individuals. Am J Clin Nutr 100, 657–666.
77.Garrard, P & Jacoby, R (2015) B-vitamin trials meta-analysis: less than meets the eye. Am J Clin Nutr 101, 414–415.
78.Smith, AD, De Jager, CA, Refsum, H et al. (2015) Homocysteine lowering, B vitamins, and cognitive aging. Am J Clin Nutr 101, 415–416.
79.Gilbody, S, Lightfoot, T & Sheldon, T (2007) Is low folate a risk factor for depression? A meta-analysis and exploration of heterogeneity. J Epidemiol Community Health 61, 631–637.
80.Kim, J-M, Stewart, R, Kim, S-W et al. (2008) Predictive value of folate, vitamin B12 and homocysteine levels in late-life depression. Br J Psychiatry 192, 268–274.
81.Ng, T-P, Feng, L, Niti, M et al. (2009) Folate, vitamin B12, homocysteine, and depressive symptoms in a population sample of older Chinese adults. J Am Geriatr Soc 57, 871–876.
82.Robinson, DJ, O'Luanaigh, C, Tehee, E et al. (2011) Associations between holotranscobalamin, vitamin B12, homocysteine and depressive symptoms in community-dwelling elders. Int J Geriatr Psychiatry 26, 307–313.
83.Merete, C, Tucker, KL & Falcon, LM (2008) Vitamin B6 is associated with depressive symptomatology in Massachusetts elders. J Am Coll Nutr 27, 421–427.
84.Skarupski, KA, Tangney, C, Li, H et al. (2010) Longitudinal association of vitamin B-6, folate, and vitamin B-12 with depressive symptoms among older adults over time. Am J Clin Nutr 92, 330–335.
85.Taylor, MJ, Carney, SM, Goodwin, GM et al. (2004) Folate for depressive disorders: systematic review and meta-analysis of randomized controlled trials. J Psychopharmacol 18, 251–256.
86.Almeida, OP, Ford, AH & Flicker, L (2015) Systematic review and meta-analysis of randomized placebo-controlled trials of folate and vitamin B12 for depression. Int Psychogeriatrics 27, 727–737.
87.McNulty, H & Pentieva, K (2010) Folate bioavailability. In Folate in Health and Disease, 2nd ed., pp. 25–47 [Bailey, LB, editor]. Boca Raton FL: CRC Press, Taylor and Francis Group.
88.McKillop, DJ, McNulty, H, Scott, JM et al. (2006) The rate of intestinal absorption of natural food folates is not related to the extent of folate conjugation. Am J Clin Nutr 84, 167–173.
89.McKillop, DJ, Pentieva, K, Daly, D et al. (2002) The effect of different cooking methods on folate retention in various foods that are amongst the major contributors to folate intake in the UK diet. Br J Nutr 88, 681.
90.Tighe, P, Ward, M, McNulty, H et al. (2011) A dose-finding trial of the effect of long-term folic acid intervention: implications for food fortification policy. Am J Clin Nutr 93, 11–18.
91.Duffy, ME, Hoey, L, Hughes, CF et al. (2014) Biomarker responses to folic acid intervention in healthy adults: a meta-analysis of randomized controlled trials. Am J Clin Nutr 99, 96–106.
92.Gibson, RS (2005) Assessment of folate and vitamin B12 status. Principles of Nutritional Assessment, 2nd ed., pp. 595–640, New York: Oxford University Press.
93.Wu, A, Chanarin, I, Slavin, G et al. (1975) Folate deficiency in the alcoholic – its relationship to clinical and haematological abnormalities, liver disease and folate stores. Br J Haematol 29, 469–478.
94.Shane, B (2011) Folate status assessment history: implications for measurement of biomarkers in NHANES. Am J Clin Nutr 94, 337S–342S.
95.IOM (1998) Folate. In Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline, pp 196–305, Washington (DC): National Academies Press (US). Available from: https://www.ncbi.nlm.nih.gov/books/NBK114310/doi: 10.17226/6015
96.EFSA NDA Panel (2014) Scientific opinion on dietary reference values for folate. EFSA J 12, 3893.
97.Cuskelly, GJ, McNulty, H & Scott, JM (1996) Effect of increasing dietary folate on red-cell folate: implications for prevention of neural tube defects. Lancet 347, 657–659.
98.McNulty, B, Pentieva, K, Marshall, B et al. (2011) Womens compliance with current folic acid recommendations and achievement of optimal vitamin status for preventing neural tube defects. Hum Reprod 26, 1530–1536.
99.Daly, L, Kirke, PM, Molloy, A et al. (1995) Folate levels and neural tube defects. JAMA 274, 1698–1702.
100.Hoey, L, McNulty, H, Askin, N et al. (2007) Effect of a voluntary food fortification policy on folate, related B vitamin status, and homocysteine in healthy adults. Am J Clin Nutr 86, 1405–1413.
101.Hopkins, SM, Gibney, MJ, Nugent, AP et al. (2015) Impact of voluntary fortification and supplement use on dietary intakes and biomarker status of folate and vitamin B-12 in Irish adults. Am J Clin Nutr 101, 1163–1172.
102.Williams, J, Mai, CT, Mulinare, J et al. (2015) Updated estimates of neural tube defects prevented by mandatory folic acid fortification-United States, 1995–2011. MMWR Morb Mortal Wkly Rep 64, 1–5.
103.De Wals, P, Tairou, F, Van Allen, MI et al. (2007) Reduction in neural-tube defects after folic acid fortification in Canada. N Engl J Med 357, 135–142.
104.Cortés, F, Mellado, C, Pardo, RA et al. (2012) Wheat flour fortification with folic acid: changes in neural tube defects rates in Chile. Am J Med Genet Part A 158A, 1885–1890.
106.SACN (2017) Folic Acid: Updated Recommendations Issued by the Scientific Advisory Committee on Nutrition. London: Public Health England.
107.Khoshnood, B, Loane, M, De Walle, H et al. (2015) Long term trends in prevalence of neural tube defects in Europe: population based study. BMJ 351, h5949.
108.McDonnell, R, Delany, V, O'Mahony, MT et al. (2015) Neural tube defects in the Republic of Ireland in 2009–11. J Public Health (Bangkok) 37, 57–63.
109.Morris, MS, Jacques, PF, Rosenberg, IH et al. (2010) Circulating unmetabolized folic acid and 5-methyltetrahydrofolate in relation to anemia, macrocytosis, and cognitive test performance in American seniors. Am J Clin Nutr 91, 1733–1744.
110.Cole, BF, Baron, JA, Sandler, RS et al. (2007) Folic acid for the prevention of colorectal adenomas. JAMA 297, 2351–2359.
111.Vollset, SE, Clarke, R, Lewington, S et al. (2013) Effects of folic acid on overall and site-specific cancer incidence during the randomised trials: meta-analyses of data on 50 000 individuals. Lancet 381, 1029–1036.
112.Pentieva, K, Selhub, J, Paul, L et al. (2016) Evidence from a randomized trial that exposure to supplemental folic acid at recommended levels during pregnancy does not lead to increased unmetabolized folic acid concentrations in maternal or cord blood. J Nutr 146, 494–500.
113.Hughes, CF, Ward, M, Hoey, L et al. (2013) Vitamin B12 and ageing: current issues and interaction with folate. Ann Clin Biochem 50, 315–329.
114.Stabler, SP (2013) Vitamin B12 deficiency. N Engl J Med 368, 2040–2042.
115.Carmel, R (2011) Biomarkers of cobalamin (vitamin B-12) status in the epidemiologic setting: a critical overview of context, applications, and performance characteristics of cobalamin, methylmalonic acid, and holotranscobalamin II. Am J Clin Nutr 94, 348S–358S.
116.Carmel, R (2013) Diagnosis and management of clinical and subclinical cobalamin deficiencies: why controversies persist in the age of sensitive metabolic testing. Biochimie 95, 1047–1055.
117.Hughes, CF & McNulty, H (2018) Assessing biomarker status of vitamin B12 in the laboratory: no simple solution. Ann Clin Biochem 55, 188–189.
118.Valente, E, Scott, JM, Ueland, PM et al. (2011) Diagnostic accuracy of holotranscobalamin, methylmalonic acid, serum cobalamin, and other indicators of tissue vitamin B12 status in the elderly. Clin Chem 57, 856–863.
119.McCormick, DB (2006) Riboflavin. In Modern Nutrition in Health and Disease, pp 391–399 [Shills, ME editor]., New York: Williams & Wilkins.
120.Powers, HJ (1999) Current knowledge concerning optimum nutritional status of riboflavin, niacin and pyridoxine. Proc Nutr Soc 58, 435–440.
121.Powers, HJ, Hill, MH, Mushtaq, S et al. (2011) Correcting a marginal riboflavin deficiency improves hematologic status in young women in the United Kingdom (RIBOFEM). Am J Clin Nutr 93, 1274–1284.
122.Rasmussen, KM, Barsa, PM & McCormick, DB (1979) Pyridoxamine (pyridoxine) 5′-phosphate oxidase activity in rat tissues during development of riboflavin or pyridoxine deficiency. Proc Soc Exp Biol Med 161, 527–530.
123.Madigan, SM, Tracey, F, McNulty, H et al. (1998) Riboflavin and vitamin B-6 intakes and status and biochemical response to riboflavin supplementation in free-living elderly people. Am J Clin Nutr 68, 389–395.
124.Whitfield, KC, Karakochuk, CD, Liu, Y et al. (2015) Poor thiamin and riboflavin status is common among women of childbearing age in rural and urban Cambodia. J Nutr 145, 628–633.
125.McAuley, E, McNulty, H, Hughes, C et al. (2016) Riboflavin status, MTHFR genotype and blood pressure: current evidence and implications for personalised nutrition. Proc Nutr Soc 75, 405–414.
127.Kehoe, L, Walton, J, Hopkins, SM et al. (2018) Intake, status and dietary sources of riboflavin in a representative sample of Irish adults aged 18–90 years. Proc Nutr Soc 77(OCE3), E66.
128.Hoey, L, McNulty, H & Strain, JJ (2009) Studies of biomarker responses to intervention with riboflavin: a systematic review. Am J Clin Nutr 89, 1960S–1980S.